National Collaborating Centre for Mental Health

STATEMENT BY DR. GAIL CHRISTOPHER, EXECUTIVE DIRECTOR OF THE NATIONAL COLLABORATIVE FOR HEALTH EQUITY

Retrieved on: 
Wednesday, October 11, 2023
Well, Algorithm, LESS, National Collaborating Centre for Mental Health, Hope, Democracy, Hatred, Mike, Supreme, Council of Senior Scholars (Saudi Arabia), Book, George Mason University, W. K. Kellogg Foundation, Workplace, Freedom, Artificial intelligence, Senior advisor, Education, ACCURATE, Appetite, Supreme court, Policy, History, Disagreement, Executive, Democrat, AND, Social media, Health equity, Research, Racism, Pessimism, Nursing, Management

WASHINGTON, Oct. 11, 2023 /PRNewswire/ -- "In our nation's history, at times, a fraction of the population and public officials have banded together to defy the aspirational principles upon which America was founded. Through each occurrence, the people, the heart of America, have united to preserve the hope of our democracy and nation governed of, by, and for the people. 

Key Points: 
  • "The National Collaborative for Health Equity (NCHE) has sponsored research demonstrating that the American public cares far more about unity and racial healing than is commonly recognized or discussed in the public discourse.
  • The Benenson Strategy Group, a premier strategic market research firm, conducted a survey using a nationally representative sample.
  • "Most Americans want to continue with the progress made toward achieving racial equity.
  • (Dr. Gail C. Christopher is the Executive Director of the National Collaborative for Health Equity , Senior Scholar at the Center for Advancement of Well-Being at George Mason University, and former Senior Advisor and Vice President of the W. K. Kellogg Foundation.

The Institute for Functional Medicine Announces Renewed Board of Directors and Celebrates Growth and Achievements in 2022 Impact Report

Retrieved on: 
Tuesday, August 1, 2023
Database, Executive, CFP, DN, Education, Public, Health equity, Accreditation Council for Continuing Medical Education, Innovation, MBA, Doctor of Philosophy, Continuing medical education, MS, Certification, Medicine, Commendation, Social justice, MD, Patient, ACCME, JD, MSES, MA, Accreditation, Accreditation Council, Functional medicine, Health, National Collaborating Centre for Mental Health, BFA, CIMA, Disease, Management, Medical device, Nursing

“I am humbled by the collective strength and unwavering commitment of our Board members,” shares Dr. Pizzorno, IFM Board Chair.

Key Points: 
  • “I am humbled by the collective strength and unwavering commitment of our Board members,” shares Dr. Pizzorno, IFM Board Chair.
  • As the IFM Board, Amy R. Mack, MSES/MPA, CEO, and staff look ahead, the organization also celebrates the recent release of its 2022 Impact Report.
  • This comprehensive report provides a high-level overview of IFM’s progress in advancing functional medicine as a patient-centered, evidence-based approach to healthcare.
  • A few of the report’s notable achievements include:
    More than 2000 total healthcare practitioners have been certified in functional medicine by IFM.

15 Communities to Advance Policies Supporting Racial Healing and Public Health

Retrieved on: 
Thursday, April 13, 2023
Private sector, Doctor of Public Health, Transformation, DN, De Beaumont Foundation, American Public Health Association, PolicyLink, City, Racism, APHA, Health, National Collaborating Centre for Mental Health, RFA, Management, MD, Policy

"American society is increasingly recognizing the impact of racism on the health of individuals and communities,” said NCHE Executive Director Gail C. Christopher, DN.

Key Points: 
  • "American society is increasingly recognizing the impact of racism on the health of individuals and communities,” said NCHE Executive Director Gail C. Christopher, DN.
  • "More than 250 states, cities, and counties have issued declarations proclaiming racism a public health crisis.
  • But now, public officials, the private sector, and communities must work together to eliminate racism and improve health outcomes, especially for people of color who have suffered through decades of health inequities."
  • Based on the Truth, Racial Healing, and Transformation frameworkTM, the policies and practices spanned five domains: narrative change, racial healing and relationship building, separation, law, and economy.

Infant Phototherapy Market Report 2023: Increases in Therapeutic Efficiency Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, January 23, 2023
Baby, Maternity, Health, Consumer, Medical Devices, Quartz, World Games, Hospital, End, TSB, Configuration, Research report, Jaundice, Bilirubin, Oil lamp, Light therapy, National Collaborating Centre for Mental Health, Infant, USB On-The-Go, Light, Death, Life, Nursing, Government, Blood, Diagnosis, Patient, IVIG, Skin, Mortality, Dräger (company), NICU, Dickson Manufacturing Company, World Health Organization, USD, WHO, Dietary supplement, Growth

The "Infant Phototherapy Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Infant Phototherapy Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • According to our research report, the Worldwide Infant Phototherapy Market was US$ 94.82 Million in 2022.
  • Increases in the effectiveness of phototherapy rise in the number of patients with neonatal jaundice are expected to drive the Global Infant Phototherapy Device Market.
  • By Type: The Global Infant Phototherapy Market is break-up into four parts:
    By Configuration: The Global Infant Photography Market is break-up into two types:
    By End Users: The Global Infant Photography Market is break-up into two types:
    Region: The Global Infant Photography Market is break-up into four types:

Infant Phototherapy Market Report 2023: Sector to Reach $117.8 Million by 2027 at a 4.4% CAGR

Retrieved on: 
Wednesday, January 25, 2023
Quartz, USD, USB On-The-Go, Hospital, Jaundice, Configuration, Nursing, IVIG, Research report, Oil lamp, Death, Life, Bilirubin, Government, Light, End, Dickson Manufacturing Company, Infant, Patient, Mortality, TSB, Skin, National Collaborating Centre for Mental Health, Dräger (company), 2052: A Global Forecast for the Next Forty Years, WHO, World Games, NICU, Diagnosis, Blood, Light therapy, World Health Organization, Dietary supplement, Growth

Global Infant Phototherapy Device Market will reach USD 117.80 Million in 2027 by expanding at a CAGR of 4.44% from 2022 to 2027, according to the publisher.

Key Points: 
  • Global Infant Phototherapy Device Market will reach USD 117.80 Million in 2027 by expanding at a CAGR of 4.44% from 2022 to 2027, according to the publisher.
  • With phototherapy, i.e., the use of light, the bilirubin level in an infant can be reduced, which leads to jaundice.
  • According to our research report, the Worldwide Infant Phototherapy Market was US$ 94.82 Million in 2022.
  • By Type: The Global Infant Phototherapy Market is break-up into four parts:
    By Configuration: The Global Infant Photography Market is break-up into two types:
    By End Users: The Global Infant Photography Market is break-up into two types:
    Region: The Global Infant Photography Market is break-up into four types:

Cancer Hope Network Announces National Collaboration With Unite Us to Increase Access to Resources for Patients and Families

Retrieved on: 
Thursday, November 17, 2022
Grief, Cancer, Faith Divides Us – Death Unites Us, Health, Foreign policy, Organization, Survivor, Strathcona County, Partnership, HITRUST, Caregiver, Hope, Hope Network, Volunteering, Research, National Collaborating Centre for Mental Health, Patient, Diagnosis, Police support volunteer, Residential care, Mobile phone

CHESTER, N.J., Nov. 17, 2022 /PRNewswire-PRWeb/ -- Cancer Hope Network, a nonprofit providing one-on-one peer support for cancer patients and caregivers, is pleased to launch a National Collaboration with Unite Us, the nation's leading technology company connecting health and social care services, to increase access to resources and services for Cancer Hope Network's patients through a secure coordinated care network.

Key Points: 
  • Cancer Hope Network, a nonprofit providing one-on-one peer support for cancer patients and caregivers, is pleased to launch a National Collaboration with Unite Us, the nation's leading technology company connecting health and social care services, to increase access to resources and services for Cancer Hope Network's patients through a secure coordinated care network.
  • CHESTER, N.J., Nov. 17, 2022 /PRNewswire-PRWeb/ -- Cancer Hope Network , a nonprofit providing one-on-one peer support for cancer patients and caregivers, is pleased to launch a National Collaboration with Unite Us , the nation's leading technology company connecting health and social care services, to increase access to resources and services for Cancer Hope Network's patients through a secure coordinated care network.
  • Cancer Hope Network was the first in the nation to provide peer support for cancer patients.
  • Cancer Hope Network has participated in regional Unite Us networks for several years, connecting with community experts and social service professionals to support individuals facing cancer.

Xenon Systems & Versity Deploy 150 PB Mass Storage System for the Pawsey Supercomputing Research Centre

Retrieved on: 
Friday, October 14, 2022
Time, Government, Efficiency, Science, Australian Government Linked Data Working Group, Metadata, XENON, List, IO, National Collaborating Centre for Mental Health, Research, Entrepreneurship, Edith Cowan University, Lists of companies, Data management, University, Murdoch University, University of Western Australia Library, HPC, Department, CEO, GLOBE, CSIRO, Astronomy, Center, Interferometry, PB, University of Western Australia, Radio, Engineering, Documentation, Information technology, Computer data storage, Banksia, Pawsey

HOOD RIVER, Ore., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Versity Software, the leading global provider of mass storage and large archive solutions, announced today that the 150 PB mass storage solution for Pawsey Supercomputing Research Centre in Perth, Australia, has been fully customized and deployed.

Key Points: 
  • HOOD RIVER, Ore., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Versity Software, the leading global provider of mass storage and large archive solutions, announced today that the 150 PB mass storage solution for Pawsey Supercomputing Research Centre in Perth, Australia, has been fully customized and deployed.
  • This project is part of a five-year contract to implement a modernized data management system for Pawsey from the Australian HPC specialist, XENON.
  • This new storage system, called "Banksia" by Pawsey, is driven by Versity's next generation Scale Out Archive Manager (ScoutAM) platform.
  • Leveraging Versity's advanced technologies, the new system enables Pawsey to maintain production access to its entire historical data collection, even after its legacy storage system has been decommissioned.

Medicare Extends Coverage of Natera's Signatera™ MRD Test to Muscle Invasive Bladder Cancer

Retrieved on: 
Monday, July 18, 2022
Research, Medicare, SEC, National Collaborating Centre for Mental Health, III, News, Recurrence, National Comprehensive Cancer Network, CLIA, Incremental cost-effectiveness ratio, Patient, Risk, ISO, Clinical Laboratory, Center, Oncology, Colorectal cancer, DNA, MIBC, Genetic testing, CMS, MRD, Hematology, Carcinoma, Neoplasm, NASDAQ, Multimedia, NTRA, Bladder cancer, Veni, vidi, vici, Medicine, Laboratory, LCD, Blood, Health, Form 10-K, Diagnosis, Guideline, Journal, FDA, American Journal of Clinical Oncology, Medical device, Medical imaging, Health insurance, Dietary supplement, Natera, Nature, Cancer

"This is great news for patients with bladder cancer, who face uncertain treatment decisions throughout the patient journey," said Solomon Moshkevich, general manager of oncology at Natera.

Key Points: 
  • "This is great news for patients with bladder cancer, who face uncertain treatment decisions throughout the patient journey," said Solomon Moshkevich, general manager of oncology at Natera.
  • We look forward to working with Medicare and with the oncology community to continue incorporating Signatera MRD assessment into standard care for patients with solid tumors."
  • This decision adds to the existing Medicare coverage for Signatera in colorectal cancer and for pan-cancer immunotherapy monitoring.
  • Signatera is a custom-built circulating tumor DNA (ctDNA) test for treatment monitoring and molecular residual disease (MRD) assessment in patients previously diagnosed with cancer.

Global Infant Phototherapy Device Market Report to 2030 - Players Include GE Healthcare, Natus Medical and Ningbo David Medical Device Among Others

Retrieved on: 
Monday, June 20, 2022
Quartz, STI, Skin, LTD, CAGR, Infant, General Electric Company, Imp, Light therapy, Method, Hemolysis, Sepsis, Bilirubin, Oil lamp, Hospital, Light, Jaundice, Growth, Bruise, Urine, Configuration, Andrews v Gas Meter Co, Light-emitting diode, Prevalence, National Collaborating Centre for Mental Health, Electric light

The global infant phototherapy device market was valued at $ 91,930.50 thousands in 2020, and is projected to reach $ 132,077.53 thousands by 2030, registering a CAGR of 3.7% from 2021 to 2030.

Key Points: 
  • The global infant phototherapy device market was valued at $ 91,930.50 thousands in 2020, and is projected to reach $ 132,077.53 thousands by 2030, registering a CAGR of 3.7% from 2021 to 2030.
  • The major factors that drive the growth of the global infant phototherapy device market include rise in prevalence of neonatal jaundice and advantages of phototherapy over other treatment methods.
  • The infant phototherapy device market is segmented on the basis of type of light lamp, configuration, end user, and region.
  • Ltd., Natus Medical Incorporated, Ningbo David Medical Device Co., LTD., Novos Medical Devices San.

Insights on the Infant Phototherapy Device Global Market to 2030 - by Light Source, Configuration, End-user and Region - ResearchAndMarkets.com

Retrieved on: 
Friday, June 17, 2022
Nursing, Health, Medical Devices, Consumer, Hospitals, Health Technology, Baby, Maternity, CAGR, Skin, Infant, Light therapy, Method, Hemolysis, Sepsis, Bilirubin, Hospital, Light, Jaundice, Growth, Bruise, Urine, Light-emitting diode, Prevalence, National Collaborating Centre for Mental Health

The "Infant Phototherapy Device Market: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Infant Phototherapy Device Market: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.
  • The global infant phototherapy device market is expected to grow at a CAGR of 3.7% from 2021 to 2030.
  • The major factors that drive the growth of the global infant phototherapy device market include rise in prevalence of neonatal jaundice and advantages of phototherapy over other treatment methods.
  • The infant phototherapy device market is segmented on the basis of type of light lamp, configuration, end user, and region.